Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Kismet typically recommends weekly or monthly treatments based on lab results and symptoms
Development was discontinued because the Phase IIb trial of 536 subjects over 24 weeks failed to meet its primary efficacy endpoint
It depends on the product and the patients insurance
Oral alternative: High-dose oral B12 (e.g
B12 vitamins alongside B6 and folate can alleviate any risk of breast cancer
US$ 20.35
US$ 21.63
US$ 22.13
US$ 26.39
US$ 29.03
US$ 25.82
US$ 28.05
US$ 22.04
US$ 26.52
US$ 27.02
US$ 29.38
US$ 22.68
US$ 29.38
US$ 27.05
